Opus Genetics, Inc.
IRD
$3.61
-$0.11-2.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -84.66% | -82.42% | 13.80% | -150.82% | -313.15% |
| Total Depreciation and Amortization | 43.24% | 130.43% | 430.00% | 1,566.67% | 825.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 145.64% | 155.49% | -43.03% | 1,005.36% | 510.16% |
| Change in Net Operating Assets | 2,587.84% | -181.72% | -169.71% | -107.91% | 95.65% |
| Cash from Operations | -27.76% | -35.11% | -37.84% | -141.78% | -177.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 3,400.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 479.52% | 286.95% | 699.56% | 40.63% | -48.49% |
| Repurchase of Common Stock | -104.11% | -104.11% | -92.41% | -73.81% | -73.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -117.30% | -108.96% | 5,797.84% | 3,806.98% | 3,940.44% |
| Cash from Financing | 348.92% | 156.58% | 1,095.01% | 228.14% | 67.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 728.99% | 438.37% | 173.19% | -1.73% | -727.09% |